-
1.发明公开
公开(公告)号：EP4389130A1
公开(公告)日：2024-06-26
申请号：EP22857846.4
申请日：2022-08-17
申请人： Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. , Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
发明人： WANG, Yandong , SU, Yingxue , CAO, Chen , WU, Meirong , XUE, Yaping , YU, Chuiliang
IPC分类号： A61K31/575 , A61P27/12
CPC分类号： A61K31/575 , A61P27/12
摘要： An application of a steroid compound in the preparation of a drug for preventing and/or treating eye floaters. The steroid compound can have good therapeutic, alleviative, and preventive effects on eye floaters, can alleviate and/or cure eye floaters to a great extent, and can improve visual clarity.
-
公开(公告)号：EP4397670A1
公开(公告)日：2024-07-10
申请号：EP22863467.1
申请日：2022-08-30
申请人： Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. , Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
发明人： YU, Chuiliang , LI, Xiaolin , WANG, Yandong , LAN, Xiaobing , HAO, Fei , SU, Yingxue , HE, Haiying , WU, Meirong
IPC分类号： C07J9/00
CPC分类号： C07J9/00
摘要： A steroidal compound, a preparation method therefor and an application thereof. On one hand, provided are a compound represented by formula I, a preparation method therefor, and an application thereof in a method for separating and purifying lanosterol; on the other hand, provided is the method for separating and purifying lanosterol. The method is simple to operate, stable in process, high in productivity and low in cost, and the obtained lanosterol has high purity and can meet medical application thereof.
-
公开(公告)号：EP4389131A1
公开(公告)日：2024-06-26
申请号：EP22857847.2
申请日：2022-08-17
申请人： Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. , Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
发明人： WANG, Yandong , SU, Yingxue , CAO, Chen , ZHOU, Sheng'an , XUE, Yaping , WU, Meirong , YU, Chuiliang
IPC分类号： A61K31/575 , A61K47/38 , A61K47/40 , A61K47/26 , A61K47/34 , A61K47/10 , A61K9/08 , A61K9/107 , A61K9/70 , A61P27/12 , A61P27/02
CPC分类号： A61K9/70 , A61K47/40 , A61K31/575 , A61K9/107 , A61P27/12 , A61K47/10 , A61K47/34 , A61K47/26 , A61K47/38 , A61P27/02 , A61K9/08
摘要： A pharmaceutical composition, a preparation method therefor and an application thereof. The pharmaceutical composition comprises the following components : a compound represented by formula I, hydroxypropyl methyl cellulose, benzalkonium chloride, and a pH regulator. The pharmaceutical composition can be used for preparing drugs for preventing or treating cataracts. The pharmaceutical composition has excellent stability in respect of exposure to light and to high temperatures, can be stored at room temperature, is convenient for patients to use, has pH and osmotic pressure close to those in the intraocular environment, is uniform in particle size distribution, and thus can give the patients good comfort.
-
公开(公告)号：EP4368180A1
公开(公告)日：2024-05-15
申请号：EP22837064.9
申请日：2022-07-08
申请人： Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. , Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
发明人： LIANG, Chiyong , WANG, Yandong , YU, Chuiliang , LI, Liang , XUE, Yaping , WU, Meirong
IPC分类号： A61K31/192 , A61P27/02 , A61P29/00
CPC分类号： A61P29/00 , A61K31/192 , A61P27/02
摘要： The present invention relates to an application of loxoprofen sodium or a composition containing loxoprofen sodium in the preparation of a drug for preventing and/or treating the dry eye disease.
-
公开(公告)号：EP4368179A1
公开(公告)日：2024-05-15
申请号：EP22837063.1
申请日：2022-07-08
申请人： Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. , Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd.
发明人： ZHOU, Shengan , YU, Chuiliang , WANG, Yandong , FENG, Ximing , LI, Yaxiong , WU, Meirong
摘要： A composition containing loxoprofen sodium. The composition comprises loxoprofen sodium, sodium hyaluronate and polysorbate 80, wherein the molecular weight of sodium hyaluronate is 0.8 × 106 - 1.6 × 106. The composition has good stability and a long shelf life and is convenient to use.
-
-
-
-
搜索结果
5 条记录 (耗时 0.011 秒)
